These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
391 related articles for article (PubMed ID: 22513294)
1. Circulating microRNAs in serum of human K-ras oncogene transgenic rats with pancreatic ductal adenocarcinomas. Yabushita S; Fukamachi K; Tanaka H; Sumida K; Deguchi Y; Sukata T; Kawamura S; Uwagawa S; Suzui M; Tsuda H Pancreas; 2012 Oct; 41(7):1013-8. PubMed ID: 22513294 [TBL] [Abstract][Full Text] [Related]
2. MicroRNA expression alterations are linked to tumorigenesis and non-neoplastic processes in pancreatic ductal adenocarcinoma. Szafranska AE; Davison TS; John J; Cannon T; Sipos B; Maghnouj A; Labourier E; Hahn SA Oncogene; 2007 Jun; 26(30):4442-52. PubMed ID: 17237814 [TBL] [Abstract][Full Text] [Related]
3. Involvement of CD40 targeting miR-224 and miR-486 on the progression of pancreatic ductal adenocarcinomas. Mees ST; Mardin WA; Sielker S; Willscher E; Senninger N; Schleicher C; Colombo-Benkmann M; Haier J Ann Surg Oncol; 2009 Aug; 16(8):2339-50. PubMed ID: 19475450 [TBL] [Abstract][Full Text] [Related]
4. MicroRNAs as diagnostic markers for pancreatic ductal adenocarcinoma and its precursor, pancreatic intraepithelial neoplasm. Xue Y; Abou Tayoun AN; Abo KM; Pipas JM; Gordon SR; Gardner TB; Barth RJ; Suriawinata AA; Tsongalis GJ Cancer Genet; 2013 Jun; 206(6):217-21. PubMed ID: 23933230 [TBL] [Abstract][Full Text] [Related]
5. Diagnostic and biological significance of microRNA-192 in pancreatic ductal adenocarcinoma. Zhao C; Zhang J; Zhang S; Yu D; Chen Y; Liu Q; Shi M; Ni C; Zhu M Oncol Rep; 2013 Jul; 30(1):276-84. PubMed ID: 23612862 [TBL] [Abstract][Full Text] [Related]
6. Upregulation of miR-194 contributes to tumor growth and progression in pancreatic ductal adenocarcinoma. Zhang J; Zhao CY; Zhang SH; Yu DH; Chen Y; Liu QH; Shi M; Ni CR; Zhu MH Oncol Rep; 2014 Mar; 31(3):1157-64. PubMed ID: 24398877 [TBL] [Abstract][Full Text] [Related]
7. Twenty-one proteins up-regulated in human H-ras oncogene transgenic rat pancreas cancers are up-regulated in human pancreas cancer. Yabushita S; Fukamachi K; Kikuchi F; Ozaki M; Miyata K; Sukata T; Deguchi Y; Tanaka H; Kakehashi A; Kawamura S; Uwagawa S; Wanibuchi H; Suzui M; Alexander DB; Tsuda H Pancreas; 2013 Aug; 42(6):1034-9. PubMed ID: 23648844 [TBL] [Abstract][Full Text] [Related]
8. miRNA-21 and miRNA-34a Are Potential Minimally Invasive Biomarkers for the Diagnosis of Pancreatic Ductal Adenocarcinoma. Alemar B; Izetti P; Gregório C; Macedo GS; Castro MA; Osvaldt AB; Matte U; Ashton-Prolla P Pancreas; 2016 Jan; 45(1):84-92. PubMed ID: 26262588 [TBL] [Abstract][Full Text] [Related]
10. Global microRNA expression profiling of microdissected tissues identifies miR-135b as a novel biomarker for pancreatic ductal adenocarcinoma. Munding JB; Adai AT; Maghnouj A; Urbanik A; Zöllner H; Liffers ST; Chromik AM; Uhl W; Szafranska-Schwarzbach AE; Tannapfel A; Hahn SA Int J Cancer; 2012 Jul; 131(2):E86-95. PubMed ID: 21953293 [TBL] [Abstract][Full Text] [Related]
11. Downregulation of miR-124 predicts poor prognosis in pancreatic ductal adenocarcinoma patients. Sun B; Liu X; Gao Y; Li L; Dong Z Br J Biomed Sci; 2016 Oct; 73(4):152-157. PubMed ID: 27922430 [TBL] [Abstract][Full Text] [Related]
12. EP300--a miRNA-regulated metastasis suppressor gene in ductal adenocarcinomas of the pancreas. Mees ST; Mardin WA; Wendel C; Baeumer N; Willscher E; Senninger N; Schleicher C; Colombo-Benkmann M; Haier J Int J Cancer; 2010 Jan; 126(1):114-24. PubMed ID: 19569050 [TBL] [Abstract][Full Text] [Related]
13. Changes in miR-143 and miR-21 expression and clinicopathological correlations in pancreatic cancers. Tavano F; di Mola FF; Piepoli A; Panza A; Copetti M; Burbaci FP; Latiano T; Pellegrini F; Maiello E; Andriulli A; di Sebastiano P Pancreas; 2012 Nov; 41(8):1280-4. PubMed ID: 22836856 [TBL] [Abstract][Full Text] [Related]
14. Specific MAPK-Associated MicroRNAs in Serum Differentiate Pancreatic Cancer from Autoimmune Pancreatitis. Akamatsu M; Makino N; Ikeda Y; Matsuda A; Ito M; Kakizaki Y; Saito Y; Ishizawa T; Kobayashi T; Furukawa T; Ueno Y PLoS One; 2016; 11(7):e0158669. PubMed ID: 27380024 [TBL] [Abstract][Full Text] [Related]
15. MicroRNAs: novel diagnostic and therapeutic tools for pancreatic ductal adenocarcinoma? Mardin WA; Mees ST Ann Surg Oncol; 2009 Nov; 16(11):3183-9. PubMed ID: 19636633 [TBL] [Abstract][Full Text] [Related]
16. In vitro modeling of human pancreatic duct epithelial cell transformation defines gene expression changes induced by K-ras oncogenic activation in pancreatic carcinogenesis. Qian J; Niu J; Li M; Chiao PJ; Tsao MS Cancer Res; 2005 Jun; 65(12):5045-53. PubMed ID: 15958547 [TBL] [Abstract][Full Text] [Related]
17. MicroRNA-10a is overexpressed in human pancreatic cancer and involved in its invasiveness partially via suppression of the HOXA1 gene. Ohuchida K; Mizumoto K; Lin C; Yamaguchi H; Ohtsuka T; Sato N; Toma H; Nakamura M; Nagai E; Hashizume M; Tanaka M Ann Surg Oncol; 2012 Jul; 19(7):2394-402. PubMed ID: 22407312 [TBL] [Abstract][Full Text] [Related]
18. Clinical potential of microRNAs in pancreatic ductal adenocarcinoma. Steele CW; Oien KA; McKay CJ; Jamieson NB Pancreas; 2011 Nov; 40(8):1165-71. PubMed ID: 22001830 [TBL] [Abstract][Full Text] [Related]
19. Expression of microRNAs in patients with pancreatic cancer and its prognostic significance. Papaconstantinou IG; Manta A; Gazouli M; Lyberopoulou A; Lykoudis PM; Polymeneas G; Voros D Pancreas; 2013 Jan; 42(1):67-71. PubMed ID: 22850622 [TBL] [Abstract][Full Text] [Related]
20. Expression of microRNA-218 in human pancreatic ductal adenocarcinoma and its correlation with tumor progression and patient survival. Zhu Z; Xu Y; Du J; Tan J; Jiao H J Surg Oncol; 2014 Feb; 109(2):89-94. PubMed ID: 24166773 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]